Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Changa

This article is a stubmissing:
Subjective Effects
Interactions
Tolerance
Legality
Changa molecule structureChanga molecule structure

Changa is a psychedelic smoking blend containing DMT infused into plant material with a monoamine oxidase inhibitor (MAOI)1, sometimes alongside other psychoactive herbs2. It is believed to have originated in Australia around 2001. MAOIs can intensify the smoked DMT experience and significantly increase its duration3, while recipes, DMT concentration, and potency vary widely between batches. MAOIs carry potentially serious interaction risks4 and require extreme caution.

Dosage & Duration

Log in Piru

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~5 mg
Light5-15 mg
Moderate15-30 mg
Strong30-50 mg
Heavy50+ mg

Dosage values are approximate; actual potency varies considerably depending on the specific blend and source material.

Duration

Onset0-2 minutes
After Effects1-36 hours
Total6-12 minutes

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacodynamics

Changa combines DMT with a monoamine oxidase inhibitor (MAOI)5. The MAOI reduces breakdown of DMT before it becomes psychoactive, which extends and intensifies DMT's effects compared with smoked DMT alone. Because recipes vary in their DMT and MAOI content, the resulting pharmacological profile can differ between batches.

Pharmacokinetics

Absorption & half-lifenot documented yetMetabolitesnone documented yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Toxicity

Respiratory

Smoking changa is reported to be harsh on the lungs and can cause respiratory discomfort during administration.

Gastrointestinal

Stomach discomfort may occur during or after use.

Central Nervous System

Headaches have been reported following use, which may persist into the following day; this is potentially related to the MAOI component, as headaches are a frequently reported side effect of MAOIs.

Psychosis Risk

Overwhelming fear and difficulty integrating experiences have been reported as negative psychological effects.

History & Culture

Origins and international spread

Changa was purportedly named and developed by Australian Julian Palmer in 2003–2004,6 although the principle of smoking harmala alkaloids with DMT had been documented by 1994, and separately smoking Banisteriopsis caapi to alter smoked DMT effects was reported by…

Legality

Legality not written up yet

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Changa article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.